Skip to main content
. 2019 Jul 22;14:1611–1631. doi: 10.2147/COPD.S184097

Table 1.

Characteristics of study participants

Healthy never-smokers Healthy smokers COPD
Number of subjects 10 20 40
Sex (male/female) 6/4 11/9 22/18
Age (years) 57.53±2.12 57.85±2.00 67.40±1.12a,b
Time since diagnosis (years) N/A N/A 7.05±1.00
Smoking exposure (pack-years) N/A 32.14±2.96 41.99±2.78b
Smoking status
(current smokers/ex-smokers)
0/0 20/0 17/23
FEV1 (% predicted) 109.4±2.77 96.88±6.26 61.98±2.76a,b
FEV1/FVC% 80.39±1.34 74.39±1.18 52.49±1.57a,b
BMI (kg/m2) 28.42±1.04 27.72±0.68 28.39±1.05
6MWT (m) N/A N/A 388.6±11.08
CAT (score) N/A N/A 15.8±1.18
mMRC (median, min–max) N/A N/A 1 (0–3)
BODE index (median, min–max) N/A N/A 1 (0–6)
Sputum macrophages (%) 65.69±3.76 56.85±1.99 44.70±41a,b
Sputum neutrophils (%) 18.89±3.77 23.28±2.23 37.40±4.93a
Sputum lymphocytes (%) 6.43±0.84 4.26±0.72 6.60±1.99
Sputum eosinophils (%) 0.89±0.28 1.43±0.28 2.93±0.95

Notes: aCOPD vs Healthy never-smokers, P<0.05; bCOPD vs Healthy smokers, P<0.05. BODE index, BMI, airway obstruction, dyspnea, exercise capacity.

Abbreviations: BMI, body mass index; 6MWT, six-minute walk test; CAT, COPD Assessment Test; mMRC, modified Medical Research Council dyspnea scale.